Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q2 2023 vs. Q1 2023
How the institutions holding Kiora Pharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 14 | 18 | +4 |
| Shares | 83.4K | 662.4K | +579.1K (+694.7%) |
| Value | $283.6K | $425.2K | +$141.6K (+49.9%) |
New holders (7)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 312,369 | $200.8K | 0.72% |
| Walleye Capital LLC | 250,258 | $162.5K | 0.00% |
| Captrust Financial Advisors | 20,000 | $12.9K | 0.00% |
| HRT Financial LP | 13,469 | $8.00K | 0.00% |
| Two Sigma Securities, LLC | 12,331 | $7.93K | 0.00% |
| Bank of America Corp | 4,892 | $3.14K | 0.00% |
| FMR LLC | 2 | $1 | 0.00% |
Sold out (3)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Citadel Advisors LLC | 14,134 | $47.2K |
| Dimensional Fund Advisors LP | 12,254 | $40.9K |
| Bank of Montreal | 10,000 | $40.4K |